<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig1">
 <label>Fig. 1</label>
 <caption>
  <p>Seroprevalence of Zika virus (ZIKV) antibodies in Central Vietnam, 2017â€“2018. The seroprevalence of Zika virus antibodies according to (
   <bold>a</bold>) age and (
   <bold>b</bold>) ethnicity. A total of 83 participants (83/801, 10.3%) demonstrated anti-ZIKV IgM antibodies as determined by using enzyme-linked immunosorbent assays. ZIKV neutralizing antibodies was determined by using plaque-reduction neutralization test (PRNT) and for confirming infection to ZIKV. Prevalence rates (anti-DENV IgG antibodies and anti-ZIKV NS1 IgG antibodies) was determined by using a total of 83 samples and 88 samples, respectively
  </p>
 </caption>
 <graphic xlink:href="12879_2020_5042_Fig1_HTML" id="MO1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
